Publications by authors named "Firas Hamdan"

Claim this Profile
R
Rates of Positive Aspiration Prior to Facial Hyaluronic Acid Filler Injections: Outcomes of a Multicenter, Cross-sectional Study.
Andreas Nikolis, Andrei Metelitsa, Luiz Avelar, Philippe Berros, Priyanka Chadha, Firas Hamdan

Aesthet Surg J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.
Salvatore Russo, Yvonne Giannoula, Sara Feola, Justin Cerioni, Firas Hamdan

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches.
Carmine D'Amico, Manlio Fusciello, Firas Hamdan, Federica D'Alessio, Paolo Bottega

Bioact Mater· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An automated and high-throughput approach for enhanced precision of adenoviral titering.
Paolo Bottega, Manlio Fusciello, Firas Hamdan, Jacopo Chiaro, Salvatore Russo

Mol Ther Methods Clin Dev· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.
Michaela Feodoroff, Firas Hamdan, Gabriella Antignani, Sara Feola, Manlio Fusciello

Oncoimmunology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplifying the injector's armamentarium: An international consensus regarding the use of gel science to differentiate hyaluronic acid fillers and guide treatment recommendations.
Andrei Metelitsa, Kaitlyn M Enright, Frank Rosengaus, Luiz Avelar, Stephanie Lam, Firas Hamdan

J Cosmet Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello

J Immunother Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.
Salvatore Russo, Sara Feola, Michaela Feodoroff, Jacopo Chiaro, Gabriella Antignani, Firas Hamdan

Mol Ther Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.
Jacopo Chiaro, Gabriella Antignani, Sara Feola, Michaela Feodoroff, Beatriz Martins, Firas Hamdan

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalizing Oncolytic Virotherapy.
Firas Hamdan, Manlio Fusciello, Vincenzo Cerullo

Hum Gene Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses.
Firas Hamdan, Michaela Feodoroff, Salvatore Russo, Manlio Fusciello, Sara Feola

Mol Ther Oncolytics· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling.
Elina A Tuovinen, Sakari Pöysti, Firas Hamdan, Kim My Le, Salla Keskitalo

J Clin Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapies: A hope for the uncurable?
Firas Hamdan, Vincenzo Cerullo

Front Mol Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.
James H A Clubb, Tatiana V Kudling, Mykhailo Girych, Lyna Haybout, Santeri Pakola, Firas Hamdan

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella.
Manlio Fusciello, Erkko Ylösmäki, Sara Feola, Arttu Uoti, Beatriz Martins, Firas Hamdan

Mol Ther Oncolytics· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine.
Sara Feola, Salvatore Russo, Beatriz Martins, Alessandra Lopes, Gaëlle Vandermeulen, Firas Hamdan

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines.
Sara Feola, Jacopo Chiaro, Beatriz Martins, Salvatore Russo, Manlio Fusciello, Firas Hamdan

Elife· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification.
Sara Feola, Markus Haapala, Karita Peltonen, Cristian Capasso, Beatriz Martins, Firas Hamdan

ACS Nano· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma.
Jacopo Chiaro, Henna H E Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Firas Hamdan

Cancer Immunol Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids.
Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro, Yvonne Giannoula, Maeve Long

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies.
Mitchell Evers, Toine Ten Broeke, J H Marco Jansen, Maaike Nederend, Firas Hamdan

MAbs· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin.
Erkko Ylösmäki, Manlio Fusciello, Beatriz Martins, Sara Feola, Firas Hamdan

J Immunother Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Derived Organoids for Precision Cancer Immunotherapy.
Mikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, Beatriz Martins, Firas Hamdan

Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses.
Firas Hamdan, Beatriz Martins, Michaela Feodoroff, Yvonne Giannoula, Sara Feola

Mol Ther Methods Clin Dev· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy.
Siri Tähtinen, Sara Feola, Cristian Capasso, Netta Laustio, Christianne Groeneveldt, Firas Hamdan

Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis